Episode Details

Back to Episodes
The Promise of Individualized HIV Prevention: Future Formulations and Dosing Intervals for Long-Acting PrEP

The Promise of Individualized HIV Prevention: Future Formulations and Dosing Intervals for Long-Acting PrEP

Episode 96 Published 4 years, 5 months ago
Description

In this episode, Nicholas Chamberlain, MD, provides an overview of the different antiretroviral drug formulations and dosing strategies in various stages of clinical development for long-acting HIV PrEP—advances that collectively offer the potential for highly individualized approaches to HIV biomedical prevention.

Presenter:

Nicholas Chamberlain, MD
Medical Director
AHF Healthcare Center – Atlanta Midtown
Department of Medicine
AIDS Healthcare Foundation
Atlanta, Georgia

Content based on an online CME program supported by an independent educational grant from Gilead Sciences, Inc.

Link to full program:
https://bit.ly/3AFvsZY


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us